Blue Owl Capital Holdings »

Proshares Tr Ii shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Proshares Tr Ii (UVXY) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Proshares Tr Ii

Tip: Access up to 7 years of quarterly data

All positions including Proshares Tr Ii held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proshares Tr Ii by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $748k 30k 24.93

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Proshares Tr Ii

Susquehanna International
Citadel Advisors
Jane Street
Wolverine Trading
SG Americas Securities
Belvedere Trading
Bank of America Corporation
Raffles Associates
Tower Research Capital
D. E. Shaw & Co
Vima
HAP Trading
Two Sigma Investments
Blue Owl Capital Holdings
Morgan Stanley

View all funds holding Proshares Tr Ii